Rheonix, Inc

📍 Ithaca, United States👥 57 employees💰 Last funded May 2012
Biotechnology Research🌐 rheonix.com
Website LinkedIn
Rheonix, Inc. is committed to improving standards of care by making molecular diagnostics available to more people, in more places, more often. As scientific knowledge evolves, so does the need for new diagnostic technology to simplify processes and enhance innovation. Rheonix, through experienced leadership and creative vision, has developed the Encompass platform, a highly customizable technology with unmatched versatility and affordability. The platform performs fully automated, complex molecular assays in an easy to use and economical format on the Rheonix CARD® cartridge. With both the Rheonix CARD and Encompass family of products, Rheonix is well-positioned to penetrate key molecular diagnostic market sectors, from reference labs through point-of-care and everywhere in-between.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Rheonix, Inc?
Rheonix, Inc has 1 investors on record on gritt.io.
When did Rheonix, Inc last raise funding?
The most recent investment in Rheonix, Inc recorded on gritt.io was in May 2012.
What industry is Rheonix, Inc in?
Rheonix, Inc operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Rheonix, Inc based?
Rheonix, Inc is headquartered in Ithaca, United States.